Close
M Halloran
M. Elizabeth Halloran

Faculty Member

Education

Affiliations

Projects

Papers

Zhang J, Litvinova M, Wang W, Wang Y, Deng X, Chen X, Li M, Zheng W, Yi L, Chen X, Wu Q, Liang Y, Wang X, Yang J, Sun K, Longini IM Jr., Halloran ME, Wu P, Cowling BJ, Merler S, Viboud C, Vespignani A, Ajelli M, Yu H. (2020). Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study. medRxiv : the preprint server for health sciences

Hladish TJ, Pearson CAB, Toh KB, Rojas DP, Manrique-Saide P, Vazquez-Prokopec GM, Halloran ME, Longini IM Jr.. (2020). Designing effective control of dengue with combined interventions. Proceedings of the National Academy of Sciences of the United States of America

Halloran ME, Longini IM, Gilbert PB. (2020). Designing a Study of Correlates of Risk for Ebola Vaccination. American journal of epidemiology

Buckee CO, Balsari S, Chan J, Crosas M, Dominici F, Gasser U, Grad YH, Grenfell B, Halloran ME, Kraemer MUG, Lipsitch M, Metcalf CJE, Meyers LA, Perkins TA, Santillana M, Scarpino SV, Viboud C, Wesolowski A, Schroeder A. (2020). Aggregated mobility data could help fight COVID-19. Science (New York, N.Y.)

Aleta A, Martin-Corral D, Pastore Y Piontti A, Ajelli M, Litvinova M, Chinazzi M, Dean NE, Halloran ME, Longini IM, Merler S, Pentland A, Vespignani A, Moro E, Moreno Y. (2020). Modeling the impact of social distancing, testing, contact tracing and household quarantine on second-wave scenarios of the COVID-19 epidemic. medRxiv : the preprint server for health sciences

Dean NE, Halloran ME, Longini IM Jr.. (2020). Temporal Confounding in the Test Negative Design. American journal of epidemiology

Ogburn EL, Bierer BE, Brookmeyer R, Choirat C, Dean NE, De Gruttola V, Ellenberg SS, Halloran ME, Hanley DF Jr., Lee JK, Wang R, Scharfstein DO. (2020). Aggregating data from COVID-19 trials. Science (New York, N.Y.), 368(6496)

Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, Pastore Y Piontti A, Rossi L, Sun K, Viboud C, Xiong X, Yu H, Halloran ME, Longini IM Jr., Vespignani A. (2020). The effect of travel restrictions on the spread of the 2019 novel coronavirus (2019-nCoV) outbreak. medRxiv : the preprint server for health sciences

Magaret AS, Jacob ST, Halloran ME, Guthrie KA, Magaret CA, Johnston C, Simon NR, Wald A. (2020). Multigroup, Adaptively Randomized Trials Are Advantageous for Comparing Coronavirus Disease 2019 (COVID-19) Interventions. Annals of internal medicine

Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, Pastore Y Piontti A, Mu K, Rossi L, Sun K, Viboud C, Xiong X, Yu H, Halloran ME, Longini IM Jr., Vespignani A. (2020). The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science (New York, N.Y.)

Kilpatrick KW, Hudgens MG, Halloran ME. (2020). Estimands and inference in cluster-randomized vaccine trials. Pharmaceutical statistics

Zhang J, Litvinova M, Wang W, Wang Y, Deng X, Chen X, Li M, Zheng W, Yi L, Chen X, Wu Q, Liang Y, Wang X, Yang J, Sun K, Longini IM Jr., Halloran ME, Wu P, Cowling BJ, Merler S, Viboud C, Vespignani A, Ajelli M, Yu H. (2020). Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. The Lancet. Infectious diseases

Dean NE, Gsell PS, Brookmeyer R, Crawford FW, Donnelly CA, Ellenberg SS, Fleming TR, Halloran ME, Horby P, Jaki T, Krause PR, Longini IM, Mulangu S, Muyembe-Tamfum JJ, Nason MC, Smith PG, Wang R, Henao-Restrepo AM, De Gruttola V. (2020). Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks. The New England journal of medicine, 382(14)

Chinazzi Matteo, Davis Jessica T, Gioannini Corrado, Litvinova Maria, Pastore Y Piontti Ana, Rossi Luca, Xiong Xinyue, Halloran M Elizabeth, Longini Ira M, Vespignani Alessandro. (2020). Preliminary assessment of the International Spreading Risk Associated with the 2019 novel Coronavirus (2019-nCoV) outbreak in Wuhan City

Diallo A, Diop OM, Diop D, Niang MN, Sugimoto JD, Ortiz JR, Faye EHA, Diarra B, Goudiaby D, Lewis KDC, Emery SL, Zangeneh SZ, Lafond KE, Sokhna C, Halloran ME, Widdowson MA, Neuzil KM, Victor JC. (2019). Effectiveness of Seasonal Influenza Vaccination in Children in Senegal During a Year of Vaccine Mismatch: A Cluster-randomized Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69(10)

Tsang TK, Ghebremariam SL, Gresh L, Gordon A, Halloran ME, Katzelnick LC, Rojas DP, Kuan G, Balmaseda A, Sugimoto J, Harris E, Longini IM Jr., Yang Y. (2019). Effects of infection history on dengue virus infection and pathogenicity. Nature communications, 10(1)

Matrajt L, Halloran ME, Antia R. (2019). Reply to Lindsey, Höschler and de Silva. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Schwartz LM, Zaman K, Yunus M, Basunia AH, Faruque ASG, Ahmed T, Rahman M, Sugimoto JD, Halloran ME, Rowhani-Rahbar A, Neuzil KM, Victor JC. (2019). Impact of Rotavirus Vaccine Introduction in Children Less Than 2 Years of Age Presenting for Medical Care With Diarrhea in Rural Matlab, Bangladesh. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69(12)

Basta NE, Halloran ME. (2019). Evaluating the Effectiveness of Vaccines Using a Regression Discontinuity Design. American journal of epidemiology, 188(6)

Matrajt L, Halloran ME, Antia R. (2019). Successes and failures of the live-attenuated influenza vaccine: can we do better?. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Potter GE, Wong J, Sugimoto J, Diallo A, Victor JC, Neuzil K, Halloran ME. (2019). Networks of face-to-face social contacts in Niakhar, Senegal. PLoS One, 14(8)

Dean NE, Gsell PS, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, Jasseh M, Nason M, Riveros X, Watson CH, Henao-Restrepo AM, Longini IM. (2019). Design of vaccine efficacy trials during public health emergencies. Science translational medicine, 11(499)

Feldstein LR, Ellis EM, Rowhani-Rahbar A, Hennessey MJ, Staples JE, Halloran ME, Weaver MR. (2019). Estimating the cost of illness and burden of disease associated with the 2014-2015 chikungunya outbreak in the U.S. Virgin Islands. PLoS neglected tropical diseases, 13(7)

Tsang TK, Chen TM, Longini IM Jr., Halloran ME, Wu Y, Yang Y. (2018). Transmissibility of Norovirus in Urban Versus Rural Households in a Large Community Outbreak in China. Epidemiology (Cambridge, Mass.), 29(5)

Zarnitsyna VI, Bulusheva I, Handel A, Longini IM, Halloran ME, Antia R. (2018). Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks. PloS one, 13(6)

Pavía-Ruz N, Diana Patricia Rojas, Salha Villanueva, Granja P, Balam-May A, Longini IM, Halloran ME, Manrique-Saide P, Gómez-Dantés H. (2018). Seroprevalence of Dengue Antibodies in Three Urban Settings in Yucatan, Mexico. The American journal of tropical medicine and hygiene, 98(4)

Fong Y, Halloran ME, Park JK, Marks F, Clemens JD, Chao DL. (2018). Efficacy of a bivalent killed whole-cell cholera vaccine over five years: a re-analysis of a cluster-randomized trial. BMC infectious diseases, 18(1)

Sun K, Zhang Q, Pastore-Piontti A, Chinazzi M, Mistry D, Dean NE, Rojas DP, Merler S, Poletti P, Rossi L, Halloran ME, Longini IM Jr., Vespignani A. (2018). Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015-2016 ZIKV epidemic. BMC medicine, 16(1)

Pasin C, Halloran ME, Gilbert PB, Langevin E, Ochiai RL, Pitisuttithum P, Capeding MR, Carrasquilla G, Frago C, Cortés M, Chambonneau L, Moodie Z. (2018). Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease. PloS one, 13(12)

Gabriel EE, Sachs MC, Daniels MJ, Halloran ME. (2019). Optimizing and evaluating biomarker combinations as trial-level general surrogates. Statistics in medicine, 38(7)

Feldstein LR, Rowhani-Rahbar A, Staples JE, Halloran ME, Ellis EM. (2018). An Assessment of Household and Individual-Level Mosquito Prevention Methods during the Chikungunya Virus Outbreak in the United States Virgin Islands, 2014-2015. The American journal of tropical medicine and hygiene, 98(3)

Bisanzio D, Dzul-Manzanilla F, Gomez-Dantes H, Pavia-Ruz N, Hladish TJ, Lenhart A, Palacio-Vargas J, González Roldan JF, Correa-Morales F, Sánchez-Tejeda G, Kuri Morales P, Manrique-Saide P, Longini IM, Halloran ME, Vazquez-Prokopec GM. (2018). Spatio-temporal coherence of dengue, chikungunya and Zika outbreaks in Merida, Mexico. PLoS neglected tropical diseases, 12(3)

Hladish TJ, Pearson CAB, Patricia Rojas D, Gomez-Dantes H, Halloran ME, Vazquez-Prokopec GM, Longini IM. (2018). Forecasting the effectiveness of indoor residual spraying for reducing dengue burden. PLoS neglected tropical diseases, 12(6)

Rojas DP, Barrera-Fuentes GA, Pavia-Ruz N, Salgado-Rodriguez M, Che-Mendoza A, Manrique-Saide P, Vazquez-Prokopec GM, Halloran ME, Longini IM, Gomez-Dantes H. (2018). Epidemiology of dengue and other arboviruses in a cohort of school children and their families in Yucatan, Mexico: Baseline and first year follow-up. PLoS neglected tropical diseases, 12(11)

Dean NE, Halloran ME, Longini IM. (2018). Design of vaccine trials during outbreaks with and without a delayed vaccination comparator. The annals of applied statistics, 12(1)

Pavía-Ruz N, Barrera-Fuentes GA, Villanueva-Jorge S, Che-Mendoza A, Campuzano-Rincón JC, Manrique-Saide P, Rojas DP, Vazquez-Prokopec GM, Halloran ME, Longini IM, Gómez-Dantés H. (2018). Dengue seroprevalence in a cohort of schoolchildren and their siblings in Yucatan, Mexico (2015-2016). PLoS neglected tropical diseases, 12(11)

Halloran ME, Hudgens MG. (2018). Comment on Laber et al. Journal of the Royal Statistical Society. Series C, Applied statistics, 67(4)

Halloran ME, Auranen K, Baird S, Basta NE, Bellan SE, Brookmeyer R, Cooper BS, DeGruttola V, Hughes JP, Lessler J, Lofgren ET, Longini IM, Onnela JP, Özler B, Seage GR, Smith TA, Vespignani A, Vynnycky E, Lipsitch M. (2017). Simulations for designing and interpreting intervention trials in infectious diseases. BMC medicine, 15(1)

Zhang Q, Sun K, Chinazzi M, Pastore Y Piontti A, Dean NE, Rojas DP, Merler S, Mistry D, Poletti P, Rossi L, Bray M, Halloran ME, Longini IM Jr., Vespignani A. (2017). Spread of Zika virus in the Americas. Proceedings of the National Academy of Sciences of the United States of America, 114(22)

Metsky HC, Matranga CB, Wohl S, Schaffner SF, Freije CA, Winnicki SM, West K, Qu J, Baniecki ML, Gladden-Young A, Lin AE, Tomkins-Tinch CH, Ye SH, Park DJ, Luo CY, Barnes KG, Shah RR, Chak B, Barbosa-Lima G, Delatorre E, Vieira YR, Paul LM, Tan AL, Barcellona CM, Porcelli MC, Vasquez C, Cannons AC, Cone MR, Hogan KN, Kopp EW, Anzinger JJ, Garcia KF, Parham LA, Ramírez RMG, Montoya MCM, Rojas DP, Brown CM, Hennigan S, Sabina B, Scotland S, Gangavarapu K, Grubaugh ND, Oliveira G, Robles-Sikisaka R, Rambaut A, Gehrke L, Smole S, Halloran ME, Villar L, Mattar S, Lorenzana I, Cerbino-Neto J, Valim C, Degrave W, Bozza PT, Gnirke A, Andersen KG, Isern S, Michael SF, Bozza FA, Souza TML, Bosch I, Yozwiak NL, MacInnis BL, Sabeti PC. (2017). Zika virus evolution and spread in the Americas. Nature, 546(7658)

Feldstein LR, Rowhani-Rahbar A, Staples JE, Weaver MR, Halloran ME, Ellis EM. (2017). Persistent Arthralgia Associated with Chikungunya Virus Outbreak, US Virgin Islands, December 2014-February 2016. Emerging infectious diseases, 23(4)

Halloran ME, Hudgens MG. (2018). Estimating population effects of vaccination using large, routinely collected data. Statistics in medicine, 37(2)

Yang Y, Meng Y, Halloran ME, Longini IM Jr.. (2018). Dependency of Vaccine Efficacy on Preexposure and Age: A Closer Look at a Tetravalent Dengue Vaccine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(2)

Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, Balmaseda A, Harris E. (2017). Antibody-dependent enhancement of severe dengue disease in humans. Science (New York, N.Y.), 358(6365)

Gabriel EE, Sachs MC, Halloran ME. (2018). Evaluation and comparison of predictive individual-level general surrogates. Biostatistics (Oxford, England), 19(3)

Yang Y, Meng Y, Halloran ME, Longini IM Jr.. (2018). Reply to Aguiar and Stollenwerk. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(4)

Schwartz LM, Halloran ME, Rowhani-Rahbar A, Neuzil KM, Victor JC. (2017). Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design. Vaccine, 35(1)

Rojas DP, Dean NE, Yang Y, Kenah E, Quintero J, Tomasi S, Ramirez EL, Kelly Y, Castro C, Carrasquilla G, Halloran ME, Longini IM. (2016). The epidemiology and transmissibility of Zika virus in Girardot and San Andres island, Colombia, September 2015 to January 2016. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 21(28)

Feldstein LR, Ellis EM, Rowhani-Rahbar A, Halloran ME, Ellis BR. (2016). The First Reported Outbreak of Chikungunya in the U.S. Virgin Islands, 2014-2015. The American journal of tropical medicine and hygiene, 95(4)

Ajelli M, Merler S, Fumanelli L, Pastore Y Piontti A, Dean NE, Longini IM Jr., Halloran ME, Vespignani A. (2016). Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis. BMC medicine, 14(1)

Dean NE, Halloran ME, Yang Y, Longini IM. (2016). Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62(10)

Gabriel EE, Daniels MJ, Halloran ME. (2016). Comparing biomarkers as trial level general surrogates. Biometrics, 72(4)

Fang LQ, Yang Y, Jiang JF, Yao HW, Kargbo D, Li XL, Jiang BG, Kargbo B, Tong YG, Wang YW, Liu K, Kamara A, Dafae F, Kanu A, Jiang RR, Sun Y, Sun RX, Chen WJ, Ma MJ, Dean NE, Thomas H, Longini IM Jr., Halloran ME, Cao WC. (2016). Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone. Proceedings of the National Academy of Sciences of the United States of America, 113(16)

Hladish TJ, Pearson CA, Chao DL, Rojas DP, Recchia GL, Gómez-Dantés H, Halloran ME, Pulliam JR, Longini IM. (2016). Projected Impact of Dengue Vaccination in Yucatán, Mexico. PLoS neglected tropical diseases, 10(5)

Koepke AA, Longini IM Jr., Halloran ME, Wakefield J, Minin VN. (2016). PREDICTIVE MODELING OF CHOLERA OUTBREAKS IN BANGLADESH. The annals of applied statistics, 10(2)

Kenah E, Britton T, Halloran ME, Longini IM Jr.. (2016). Molecular Infectious Disease Epidemiology: Survival Analysis and Algorithms Linking Phylogenies to Transmission Trees. PLoS computational biology, 12(4)

Halloran ME, Hudgens MG. (2016). Dependent Happenings: A Recent Methodological Review. Current epidemiology reports, 3(4)

Merler S, Ajelli M, Fumanelli L, Parlamento S, Pastore Y Piontti A, Dean NE, Putoto G, Carraro D, Longini IM Jr., Halloran ME, Vespignani A. (2016). Containing Ebola at the Source with Ring Vaccination. PLoS neglected tropical diseases, 10(11)

Zhou J, Chu H, Hudgens MG, Halloran ME. (2016). A Bayesian approach to estimating causal vaccine effects on binary post-infection outcomes. Statistics in medicine, 35(1)

Schwartz LM, Halloran ME, Durbin AP, Longini IM Jr.. (2015). The dengue vaccine pipeline: Implications for the future of dengue control. Vaccine, 33(29)

Merler S, Ajelli M, Fumanelli L, Gomes MF, Piontti AP, Rossi L, Chao DL, Longini IM Jr., Halloran ME, Vespignani A. (2015). Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational modelling analysis. The Lancet. Infectious diseases, 15(2)

Yang Y, Zhang Y, Fang L, Halloran ME, Ma M, Liang S, Kenah E, Britton T, Chen E, Hu J, Tang F, Cao W, Feng Z, Longini IM Jr.. (2015). Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 20(10)

Chao DL, Park JK, Marks F, Ochiai RL, Longini IM, Halloran ME. (2015). The contribution of neighbours to an individual's risk of typhoid outcome. Epidemiology and infection, 143(16)

Lipsitch M, Eyal N, Halloran ME, Hernán MA, Longini IM, Perencevich EN, Grais RF. (2015). Vaccine testing. Ebola and beyond. Science (New York, N.Y.), 348(6230)

Lessler J, Edmunds WJ, Halloran ME, Hollingsworth TD, Lloyd AL. (2015). Seven challenges for model-driven data collection in experimental and observational studies. Epidemics, (10)

Matrajt L, Britton T, Halloran ME, Longini IM Jr.. (2015). One versus two doses: What is the best use of vaccine in an influenza pandemic?. Epidemics, (13)

Yang Y, Halloran ME, Chen Y, Kenah E. (2014). A pathway EM-algorithm for estimating vaccine efficacy with a non-monotone validation set. Biometrics, 70(3)

Halloran ME, Vespignani A, Bharti N, Feldstein LR, Alexander KA, Ferrari M, Shaman J, Drake JM, Porco T, Eisenberg JN, Del Valle SY, Lofgren E, Scarpino SV, Eisenberg MC, Gao D, Hyman JM, Eubank S, Longini IM Jr.. (2014). Ebola: mobility data. Science (New York, N.Y.), 346(6208)

Poletto C, Gomes MF, Pastore y Piontti A, Rossi L, Bioglio L, Chao DL, Longini IM, Halloran ME, Colizza V, Vespignani A. (2014). Assessing the impact of travel restrictions on international spread of the 2014 West African Ebola epidemic. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 19(42)

Lofgren ET, Halloran ME, Rivers CM, Drake JM, Porco TC, Lewis B, Yang W, Vespignani A, Shaman J, Eisenberg JN, Eisenberg MC, Marathe M, Scarpino SV, Alexander KA, Meza R, Ferrari MJ, Hyman JM, Meyers LA, Eubank S. (2014). Opinion: Mathematical models: a key tool for outbreak response. Proceedings of the National Academy of Sciences of the United States of America, 111(51)

Halloran ME, Longini IM Jr.. (2014). Emerging, evolving, and established infectious diseases and interventions. Science (New York, N.Y.), 345(6202)

Tran CH, Sugimoto JD, Pulliam JR, Ryan KA, Myers PD, Castleman JB, Doty R, Johnson J, Stringfellow J, Kovacevich N, Brew J, Cheung LL, Caron B, Lipori G, Harle CA, Alexander C, Yang Y, Longini IM Jr., Halloran ME, Morris JG Jr., Small PA Jr.. (2014). School-located influenza vaccination reduces community risk for influenza and influenza-like illness emergency care visits. PloS one, 9(12)

Gomes MF, Pastore Y Piontti A, Rossi L, Chao D, Longini I, Halloran ME, Vespignani A. (2014). Assessing the international spreading risk associated with the 2014 west african ebola outbreak. PLoS currents, (6)

VanderWeele TJ, Tchetgen Tchetgen EJ, Halloran ME. (2014). Interference and Sensitivity Analysis. Statistical science : a review journal of the Institute of Mathematical Statistics, 29(4)

Sugimoto JD, Koepke AA, Kenah EE, Halloran ME, Chowdhury F, Khan AI, LaRocque RC, Yang Y, Ryan ET, Qadri F, Calderwood SB, Harris JB, Longini IM Jr.. (2014). Household Transmission of Vibrio cholerae in Bangladesh. PLoS neglected tropical diseases, 8(11)

Dimitrov DT, Troeger C, Halloran ME, Longini IM, Chao DL. (2014). Comparative effectiveness of different strategies of oral cholera vaccination in bangladesh: a modeling study. PLoS neglected tropical diseases, 8(12)

Chao DL, Longini IM Jr., Halloran ME. (2013). The effects of vector movement and distribution in a mathematical model of dengue transmission. PLoS One, 8(10)

Matrajt L, Halloran ME, Longini IM Jr.. (2013). Optimal vaccine allocation for the early mitigation of pandemic influenza. PLoS computational biology, 9(3)

Auranen K, Rinta-Kokko H, Halloran ME. (2013). Estimating strain-specific and overall efficacy of polyvalent vaccines against recurrent pathogens from a cross-sectional study. Biometrics, 69(1)

Vanderweele TJ, Tchetgen Tchetgen EJ, Halloran ME. (2012). Components of the indirect effect in vaccine trials: identification of contagion and infectiousness effects. Epidemiology (Cambridge, Mass.), 23(5)

Chao DL, Halstead SB, Halloran ME, Longini IM Jr.. (2012). Controlling dengue with vaccines in Thailand. PLoS neglected tropical diseases, 6(10)

Yang Y, Longini IM Jr., Halloran ME, Obenchain V. (2012). A hybrid EM and Monte Carlo EM algorithm and its application to analysis of transmission of infectious diseases. Biometrics, 68(4)

Halloran ME, Hudgens MG. (2012). Comparing bounds for vaccine effects on infectiousness. Epidemiology (Cambridge, Mass.), 23(6)

Halloran ME, Hudgens MG. (2012). Causal inference for vaccine effects on infectiousness. The international journal of biostatistics, 8(2)

Halloran ME. (2012). The Minicommunity Design to Assess Indirect Effects of Vaccination. Epidemiologic methods, 1(1)

Potter GE, Handcock MS, Longini IM Jr., Halloran ME. (2012). ESTIMATING WITHIN-SCHOOL CONTACT NETWORKS TO UNDERSTAND INFLUENZA TRANSMISSION. The annals of applied statistics, 6(1)

Chao DL, Matrajt L, Basta NE, Sugimoto JD, Dean B, Bagwell DA, Oiulfstad B, Halloran ME, Longini IM Jr.. (2011). Planning for the control of pandemic influenza A (H1N1) in Los Angeles County and the United States. American journal of epidemiology, 173(10)

Chao DL, Halloran ME, Longini IM Jr.. (2011). Vaccination strategies for epidemic cholera in Haiti with implications for the developing world. Proceedings of the National Academy of Sciences of the United States of America, 108(17)

Kenah E, Chao DL, Matrajt L, Halloran ME, Longini IM Jr.. (2011). The global transmission and control of influenza. PLoS One, 6(5)

Potter GE, Handcock MS, Longini IM Jr., Halloran ME. (2011). ESTIMATING WITHIN-HOUSEHOLD CONTACT NETWORKS FROM EGOCENTRIC DATA. The annals of applied statistics, 5(3)

Chao DL, Halloran ME, Obenchain VJ, Longini IM Jr.. (2010). FluTE, a publicly available stochastic influenza epidemic simulation model. PLoS computational biology, 6(1)

Chao DL, Halloran ME, Longini IM Jr.. (2010). School opening dates predict pandemic influenza A(H1N1) outbreaks in the United States. The Journal of infectious diseases, 202(6)

Yang Y, Halloran ME, Daniels MJ, Longini IM Jr., Burke DS, Cummings DA. (2010). Modeling Competing Infectious Pathogens from a Bayesian Perspective: Application to Influenza Studies with Incomplete Laboratory Results. Journal of the American Statistical Association, 105(492)

Halloran ME. (2009). On influenza and school closings: time for prospective studies. Epidemiology (Cambridge, Mass.), 20(6)

Halloran ME, Holmes EC. (2009). Invited commentary: Evaluating vaccination programs using genetic sequence data. American journal of epidemiology, 170(12)

Basta NE, Chao DL, Halloran ME, Matrajt L, Longini IM Jr.. (2009). Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States. American journal of epidemiology, 170(6)

Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, Potter G, Kenah E, Longini IM Jr.. (2009). The transmissibility and control of pandemic influenza A (H1N1) virus. Science (New York, N.Y.), 326(5953)

Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM Jr., Dye C, Halloran ME. (2009). Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proceedings of the National Academy of Sciences of the United States of America, 106(33)

Yang Y, Halloran ME, Longini IM Jr.. (2009). A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infections. Biostatistics (Oxford, England), 10(2)

Sander B, Nizam A, Garrison LP Jr., Postma MJ, Halloran ME, Longini IM Jr.. (2008). Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 12(2)

Halloran ME, Ferguson NM, Eubank S, Longini IM Jr., Cummings DA, Lewis B, Xu S, Fraser C, Vullikanti A, Germann TC, Wagener D, Beckman R, Kadau K, Barrett C, Macken CA, Burke DS, Cooley P. (2008). Modeling targeted layered containment of an influenza pandemic in the United States. Proceedings of the National Academy of Sciences of the United States of America, 105(12)

Hudgens MG, Halloran ME. (2008). Toward Causal Inference With Interference. Journal of the American Statistical Association, 103(482)

Basta NE, Halloran ME, Matrajt L, Longini IM Jr.. (2008). Estimating influenza vaccine efficacy from challenge and community-based study data. American journal of epidemiology, 168(12)

Yang Y, Gilbert P, Longini IM, Halloran ME. (2008). A Bayesian Framework for Estimating Vaccine Efficacy per Infectious Contact. The annals of applied statistics, 2(4)

Halloran ME, Piedra PA, Longini IM Jr., Gaglani MJ, Schmotzer B, Fewlass C, Herschler GB, Glezen WP. (2007). Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. Vaccine, 25(20)

Yang Y, Longini IM, Halloran ME. (2007). A Data-Augmentation Method for Infectious Disease Incidence Data from Close Contact Groups. Computational statistics & data analysis, 51(12)

Struchiner CJ, Halloran ME. (2007). Randomization and baseline transmission in vaccine field trials. Epidemiology and infection, 135(2)

Yang Y, Halloran ME, Sugimoto JD, Longini IM Jr.. (2007). Detecting human-to-human transmission of avian influenza A (H5N1). Emerging infectious diseases, 13(9)

Yang Y, Longini IM, Halloran ME. (2007). A Resampling-Based Test to Detect Person-To-Person Transmission of Infectious Disease. The annals of applied statistics, 1(1)

Halloran ME. (2006). Invited commentary: Challenges of using contact data to understand acute respiratory disease transmission. American journal of epidemiology, 164(10)

Longini IM Jr., Halloran ME, Nizam A, Yang Y, Xu S, Burke DS, Cummings DA, Epstein JM. (2007). Containing a large bioterrorist smallpox attack: a computer simulation approach. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 11(2)

Halloran ME, Hayden FG, Yang Y, Longini IM Jr., Monto AS. (2007). Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. American journal of epidemiology, 165(2)

Halloran ME, Longini IM Jr.. (2006). Public health. Community studies for vaccinating schoolchildren against influenza. Science (New York, N.Y.), 311(5761)

Halloran ME. (2006). Overview of vaccine field studies: types of effects and designs. Journal of biopharmaceutical statistics, 16(4)

Yang Y, Longini IM Jr., Halloran ME. (2006). Design and Evaluation of Prophylactic Interventions Using Infectious Disease Incidence Data from Close Contact Groups. Journal of the Royal Statistical Society. Series C, Applied statistics, 55(3)

Hudgens MG, Halloran ME. (2006). Causal Vaccine Effects on Binary Postinfection Outcomes. Journal of the American Statistical Association, 101(473)

Patel R, Longini IM Jr., Halloran ME. (2005). Finding optimal vaccination strategies for pandemic influenza using genetic algorithms. Journal of theoretical biology, 234(2)

Longini IM Jr., Halloran ME. (2005). Strategy for distribution of influenza vaccine to high-risk groups and children. American journal of epidemiology, 161(4)

Longini IM Jr., Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DA, Halloran ME. (2005). Containing pandemic influenza at the source. Science (New York, N.Y.), 309(5737)

Longini IM Jr., Halloran ME, Nizam A, Yang Y. (2004). Containing pandemic influenza with antiviral agents. American journal of epidemiology, 159(7)

Chu H, Halloran ME. (2004). Estimating vaccine efficacy using auxiliary outcome data and a small validation sample. Statistics in medicine, 23(17)

Glezen WP, Piedra PA, Longini IM, Halloran ME. (2004). Safety of cold-adapted live influenza vaccine. The Pediatric infectious disease journal, 23(6)

Chu H, Halloran ME. (2004). Bayesian estimation of vaccine efficacy. Clinical trials (London, England), 1(3)

Chu H, Préziosi MP, Halloran ME. (2004). Estimating heterogeneous transmission with multiple infectives using MCMC methods. Statistics in medicine, 23(1)

Préziosi MP, Halloran ME. (2003). Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. Vaccine, 21(17-18)

Halloran ME, Longini IM Jr., Gaglani MJ, Piedra PA, Chu H, Herschler GB, Glezen WP. (2003). Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. American journal of epidemiology, 158(4)

Préziosi MP, Halloran ME. (2003). Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 37(6)

Halloran ME, Longini IM Jr., Nizam A, Yang Y. (2002). Containing bioterrorist smallpox. Science (New York, N.Y.), 298(5597)

Longini IM Jr., Halloran ME, Nizam A. (2002). Model-based estimation of vaccine effects from community vaccine trials. Statistics in medicine, 21(4)

Halloran ME, Longini IM, Cowart DM, Nizam A. (2002). Community interventions and the epidemic prevention potential. Vaccine, 20(27-28)

Halloran ME, Longini IM Jr.. (2001). Using validation sets for outcomes and exposure to infection in vaccine field studies. American journal of epidemiology, 154(5)

Halloran ME, Longini IM Jr., Struchiner CJ. (1999). Design and interpretation of vaccine field studies. Epidemiologic reviews, 21(1)

Longini IM Jr., Sagatelian K, Rida WN, Halloran ME. (1998). Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations. Statistics in medicine, 17(10)

Stephens DS, Levin B, Halloran ME. (1998). Symposium on population biology, evolution, and control of infectious diseases. Introduction. The American journal of the medical sciences, 315(2)

Halloran ME, Anderson RM, Azevedo-Neto RS, Bellini WJ, Branch O, Burke MA, Compans R, Day K, Gooding L, Gupta S, Katz J, Kew O, Keyserling H, Krause R, Lal AA, Massad E, McLean AR, Rosa P, Rota P, Wiener P, Wynn SG, Zanetta DM. (1998). Population biology, evolution, and immunology of vaccination and vaccination programs. The American journal of the medical sciences, 315(2)

Halloran ME, Struchiner CJ, Longini IM Jr.. (1997). Study designs for evaluating different efficacy and effectiveness aspects of vaccines. American journal of epidemiology, 146(10)

Bertolli J, Pangi C, Frerichs R, Halloran ME. (1997). A case-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon, Myanmar. International journal of epidemiology, 26(4)

Mosure DJ, Berman S, Kleinbaum D, Halloran ME. (1996). Predictors of Chlamydia trachomatis infection among female adolescents: a longitudinal analysis. American journal of epidemiology, 144(10)

Longini IM Jr., Datta S, Halloran ME. (1996). Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 13(5)

Antia R, Halloran ME. (1996). Recent developments in theories of pathogenesis of AIDS. Trends in microbiology, 4(7)

Halloran ME, Longini IM Jr., Struchiner CJ. (1996). Estimability and interpretation of vaccine efficacy using frailty mixing models. American journal of epidemiology, 144(1)

Halloran ME. (1996). Epidemiologic effects of varicella vaccination. Infectious disease clinics of North America, 10(3)

Longini IM Jr., Halloran ME. (1995). AIDS: modeling epidemic control. Science (New York, N.Y.), 267(5202)

Haber M, Watelet L, Halloran ME. (1995). On individual and population effectiveness of vaccination. International journal of epidemiology, 24(6)

Halloran ME, Struchiner CJ. (1995). Causal inference in infectious diseases. Epidemiology (Cambridge, Mass.), 6(2)

Noronha CP, Struchiner CJ, Halloran ME. (1995). Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study. International journal of epidemiology, 24(5)

Halloran ME, Longini IM Jr., Haber MJ, Struchiner CJ, Brunet RC. (1994). Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field. Statistics in medicine, 13(4)

Halloran ME, Cochi SL, Lieu TA, Wharton M, Fehrs L. (1994). Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. American journal of epidemiology, 140(2)

Halloran ME. (1994). Mycobacterium tuberculosis: just desserts for an ungrateful guest. Trends in ecology & evolution, 9(2)

Halloran ME, Watelet L, Struchiner CJ. (1994). Epidemiologic effects of vaccines with complex direct effects in an age-structured population. Mathematical biosciences, 121(2)

Devine OJ, Louis TA, Halloran ME. (1994). Empirical Bayes methods for stabilizing incidence rates before mapping. Epidemiology (Cambridge, Mass.), 5(6)

Halloran ME. (1993). Salmonella enteritidis infections in France and the United States: causes vs causal models. American journal of public health, 83(12)

Brunet RC, Struchiner CJ, Halloran ME. (1993). On the distribution of vaccine protection under heterogeneous response. Mathematical biosciences, 116(1)

Schapira A, Beales PF, Halloran ME. (1993). Malaria: living with drug resistance. Parasitology today (Personal ed.), 9(5)

Halloran ME. (1992). Persistence, drugs and rock'n'roll. Trends in ecology & evolution, 7(7)

Halloran ME, Struchiner CJ. (1992). Modeling transmission dynamics of stage-specific malaria vaccines. Parasitology today (Personal ed.), 8(3)

Struchiner CJ, Halloran ME. (1992). Modeling AIDS vaccines: the cellular level. Memorias do Instituto Oswaldo Cruz, 87(1)

Halloran ME, Haber M, Longini IM Jr.. (1992). Interpretation and estimation of vaccine efficacy under heterogeneity. American journal of epidemiology, 136(3)

Halloran ME, Haber M, Longini IM Jr., Struchiner CJ. (1991). Direct and indirect effects in vaccine efficacy and effectiveness. American journal of epidemiology, 133(4)

Halloran ME, Struchiner CJ. (1991). Study designs for dependent happenings. Epidemiology (Cambridge, Mass.), 2(5)

Haber M, Longini IM Jr., Halloran ME. (1991). Measures of the effects of vaccination in a randomly mixing population. International journal of epidemiology, 20(1)

Haber M, Longini IM Jr., Halloran ME. (1991). Estimation of vaccine efficacy in outbreaks of acute infectious diseases. Statistics in medicine, 10(10)

Longini IM Jr., Haber MJ, Halloran ME. (1990). [Direct and indirect effects of vaccines: an annotation on the estimation of the vaccine efficacy from outbreaks caused by acute infection agents such as measles]. Boletin medico del Hospital Infantil de Mexico, 47(7)

Halloran ME, Struchiner CJ, Spielman A. (1989). Modeling malaria vaccines. II: Population effects of stage-specific malaria vaccines dependent on natural boosting. Mathematical biosciences, 94(1)

Halloran ME, Bundy DA, Pollitt E. (1989). Infectious disease and the Unesco basic education initiative. Parasitology today (Personal ed.), 5(11)